Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis

This post hoc exploratory analysis found no clear associations between frequently used concomitant medication combinations and disease progression in 1450 patients with IPF enrolled in phase III trials, but several combinations may require further study. http://bit.ly/2ZzyMXR

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Respir J
Main Authors: Kreuter, Michael, Lederer, David J., Cottin, Vincent, Kahn, Nicolas, Ley, Brett, Vancheri, Carlo, Weycker, Derek, Atwood, Mark, Kirchgaessler, Klaus-Uwe, Ryerson, Christopher J.
Formato: Artigo
Idioma:Inglês
Publicado em: European Respiratory Society 2019
Assuntos:
Agora
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6906546/
https://ncbi.nlm.nih.gov/pubmed/31537696
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.01188-2019
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados